Vertex Pharmaceuticals Inc (VRTX)
Debt-to-assets ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total assets | US$ in thousands | 22,730,200 | 18,150,900 | 13,432,500 | 11,751,800 | 8,318,460 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $22,730,200K
= 0.00
The debt-to-assets ratio of Vertex Pharmaceuticals, Inc. has been decreasing over the past five years, indicating a positive trend towards lower reliance on debt to finance its assets. In 2019, the ratio was 0.07, which means that 7% of the company's assets were financed by debt. However, by the end of 2023, the ratio had decreased to 0.02, suggesting that only 2% of Vertex Pharmaceuticals' assets are now financed by debt. This improvement in the debt-to-assets ratio reflects the company's ability to manage its debt levels effectively and may indicate a stronger financial position with lower financial risk.
Peer comparison
Dec 31, 2023